3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
18
Rectal Neoplasms
7
Colorectal Neoplasms
5
Carcinoma, Intraductal, Noninfiltrating
4
Neoplasms
3
Breast Carcinoma In Situ
3
Urinary Bladder Neoplasms
2
Sarcoma
2
Esophageal Squamous Cell Carcinoma
2
Esophageal Neoplasms
2
Colonic Neoplasms
2
Bites and Stings
2
Uterine Cervical Neoplasms
1
Testicular Neoplasms
1
Stress, Psychological
1
Stomach Neoplasms
1
Small Cell Lung Carcinoma
1
Seminoma
1
Rhabdoid Tumor
1
Retinoblastoma
1
Prostatic Neoplasms
1
Peritoneal Metastases From Gastric Cancer
1
Peritoneal Metastases From Colorectal Cancer
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Neoplasm, Residual
1
Neoadjuvant Therapy in Elderly HER2-Positive Breast Cancer
1
Muscle Invasive Bladder Cancer
1
Motor Activity
1
Interventions
Standard of Care
6
Surveys and Questionnaires
2
Interviews as Topic
2
zaleplon
1
olanzapine-fluoxetine combination
1
Videotape Recording
1
Rehabilitation
1
Referral and Consultation
1
Olanzapine
1
Neoadjuvant Therapy
1
Health Services Needs and Demand
1
Fluoxetine
1
Decision Support Techniques
1
Counseling
1
Control Groups
1
Acupuncture Therapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Advanced Cancer
×
Neoadjuvant Therapy
×
Clear all
NCT04257786
2020-02-06
ovarian cancer
Assiut University
Phase NA
Unknown
80 enrolled